1215 GMT -- Schering (SHR) +2.6% at EUR85.17 on a report saying Bayer would bid for Schering if the latter viewed its offer as friendly, notes a trader. Adds the bid would have to be higher than Merck’s (MRK.XE) hostile EUR77/share bid for it to be successful with Schering shareholders. View EUR86/share to EUR90/share as realistic, they add. Schering declines comment, Bayer not immediately available for comment. Bayer +0.7% at EUR34. (HRU/JEL)
